Although increasing evidence confirms neuropsychiatric manifestations associated mainly
with severe COVID-19 infection, long-term neuropsychiatric dysfunction (recently …

One increasingly documented tendency of COVID-19 patients is to exhibit neuropsychiatric
and neurological symptoms. Here we found that anxiety and cognitive impairment are …

The most dire consequences of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection may not manifest during the initial infection but appear later and are …

Worldwide, over 694 million people have been infected with SARS-CoV-2, with an estimated
55–60% of those infected developing COVID-19. Since the beginning of the pandemic in …

In December 2019, a pneumonia outbreak was reported in Wuhan, Hubei province, China.
Since then, the World Health Organization declared a public health emergency of …

The neurotropism of SARS-CoV-2 and the phenotypes of infected neurons are still in
debate. Long COVID manifests with “brain diseases” and the cause of these brain …

Neurological symptoms, including cognitive impairment and fatigue, can occur in both the
acute infection phase of coronavirus disease 2019 (COVID-19) and at later stages, yet the …

Neurological manifestations are a significant complication of coronavirus disease (COVID-
19), but underlying mechanisms aren't well understood. The development of animal models …

Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
associated with acute and postacute cognitive and neuropsychiatric symptoms including …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
coronavirus disease 2019 (COVID-19) for which there have been over 50 million confirmed …